Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (201-210 of 211) with videos related to

Pageof 22
Sort By:
Ugeskrift for Laeger|August 12, 1991
[Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial]C Rose, J A Andersen, K W Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary resultsM Blichert-Toft, H Brincker, J A Andersen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancerL Gianni, P Dombernowsky, G Sledge, et al.
Ugeskrift for Laeger|August 12, 1991
[Adjuvant chemotherapy in premenopausal and menopausal high-risk patients with breast cancer. 4. Results of the DBCG (Danish Breast Cancer Cooperative Group) 77B study]P Dombernowsky, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Rationalization profits of radiographic diagnosis with systematic follow-up DBCG (Danish Breast Cancer Cooperative Group) programs. 1]H S Thomsen, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group)]C K Axelsson, J A Andersen, K W Andersen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patientsA T van Oosterom, H T Mouridsen, O S Nielsen, et al.
Anti-Cancer Drugs|October 18, 2001
Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancerC R Underhill, F X Parnis, M S Highley, et al.
Anti-Cancer Drugs|August 7, 2001
Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9J H Schellens, P Dombernowsky, J Cassidy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetateP Dombernowsky, I Smith, G Falkson, et al.
Pageof 22

Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
Ugeskrift for Laeger|August 12, 1991
[Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial]C Rose, J A Andersen, K W Andersen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary resultsM Blichert-Toft, H Brincker, J A Andersen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancerL Gianni, P Dombernowsky, G Sledge, et al.
Ugeskrift for Laeger|August 12, 1991
[Adjuvant chemotherapy in premenopausal and menopausal high-risk patients with breast cancer. 4. Results of the DBCG (Danish Breast Cancer Cooperative Group) 77B study]P Dombernowsky, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Rationalization profits of radiographic diagnosis with systematic follow-up DBCG (Danish Breast Cancer Cooperative Group) programs. 1]H S Thomsen, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group)]C K Axelsson, J A Andersen, K W Andersen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patientsA T van Oosterom, H T Mouridsen, O S Nielsen, et al.
Anti-Cancer Drugs|October 18, 2001
Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancerC R Underhill, F X Parnis, M S Highley, et al.
Anti-Cancer Drugs|August 7, 2001
Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9J H Schellens, P Dombernowsky, J Cassidy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetateP Dombernowsky, I Smith, G Falkson, et al.
Pageof 22